Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Quest Diagnostics Announces One Day Extension of Offer to Acquire Celera to 5pm Today

May 3, 2011 By Bio-Medicine.Org

MADISON, N.J., May 3, 2011 /PRNewswire/ — Quest Diagnostics
Incorporated (NYSE:
DGX
), the world’s leading provider of diagnostic testing,
information and services, announced today that Spark Acquisition
Corporation, its wholly owned subsidiary (“Spark”), has extended
the expiration of its tender offer to acquire all outstanding
shares of common stock of Celera Corporation (NASDAQ:
CRA) for $8.00 per share in cash, to 5:00 p.m., New York City
time, today, May 3, 2011, unless further extended in accordance
with the Merger Agreement (as defined below) and the applicable
rules and regulations of the Securities and Exchange Commission.
 

Computershare Trust Company, N.A., the depositary for the tender
offer, has indicated that, as of 5:00 p.m., New York City time, on
May 2, 2011, 82,181,869 shares of common stock of Celera were
issued and outstanding, and 40,451,233 shares of common stock of
Celera have been tendered into and not properly withdrawn from the
tender offer.  These shares represent approximately 49.22% of
Celera’s outstanding shares of common stock and 46.10% of Celera’s
outstanding shares of common stock on a fully diluted basis (as
determined pursuant to the Merger Agreement, as defined below).
 In addition, the depositary has received commitments to
tender approximately 5,588,479 shares of common stock of Celera in
accordance with the guaranteed delivery procedures, which, when
combined with the shares tendered and not properly withdrawn from
the tender offer, represent approximately 56.02% of Celera’s
outstanding shares of common stock and 52.47% of Celera’s
outstanding shares of common stock on a fully diluted basis (as
determined pursuant to the Merger Agreement).

The tender offer was previously scheduled to expire at 5:00
p.m., New York City time, on May 2, 20

‘/>”/>

SOURCE

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech